CompletedInterventionalPhase 3Updated May 30, 2011
Dermal Tolerability of Dapsone Gel in Healthy Volunteers | NCT02117752 | Trialant
CompletedInterventionalPhase 1Updated Oct 9, 2018
Dermal Tolerability of Dapsone Gel in Healthy Volunteers
ClinicalTrials.gov ID
NCT02117752
Lead Sponsor
Almirall, S.A.INDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 1
Enrollment
237Actual
Last Update Posted
Oct 9, 2018Actual
Start Date
Apr 2014
Primary Completion Date
Jul 2014Actual
Completion Date
Jul 2014Actual
Brief Summary
This study will determine the cumulative irritation potential and sensitization potential of dapsone gel and vehicle after repeat applications on the skin of healthy volunteers.
Healthy Volunteers
dapsone gel
dapsone gel vehicle
sodium lauryl sulfate
Normal saline
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
-Healthy adults.
Exclusion Criteria:
Skin diseases, excessive hair, tattoos, pigmentation, scars or moles that could interfere with patch application